SOMERSET, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, commemorates a decade-long partnership with Delaney Radiology and the indispensable role played by CareCloud's release of information (ROI) program throughout the past 10 years. This enduring collaboration has helped transform Delaney Radiology's operations, empowering them to streamline their medical records processes and channel their resources towards providing unparalleled patient care.
The Delaney Radiology facility offers a wide range of cutting-edge services, including various medical imaging services and screenings. As a leading radiology center, Delaney Radiology handles a substantial volume of medical records requests from attorneys, disability agencies, and liability insurances. Managing these requests is typically a labor-intensive and non-billable task for most healthcare practices.
Ten years ago, Delaney Radiology made the strategic decision to partner with CareCloud and enlist their ROI division to handle the intricate task of processing medical records requests. CareCloud's ROI program offered a comprehensive set of advantages that significantly alleviated the administrative burden on Delaney Radiology's staff:
Robin Marshall, director of accounts receivable at Delaney Radiology, expressed their satisfaction with the partnership. "CareCloud's release of information program has been a game-changer for our practice," Marshall stated. "It has saved us substantial time and money in labor costs, allowing us to focus on delivering top-notch radiology services. We trust CareCloud implicitly due to their exceptional service quality and professionalism."
Marshall's positive experience with CareCloud's ROI services even led her to recommend CareCloud to another radiology practice. This word-of-mouth referral emphasizes the confidence and trust that Delaney Radiology has in CareCloud's capabilities.
For more information about CareCloud's comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.
About CareCloud
CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
SOURCE CareCloud
Company Contact:
Bill Korn
Chief Strategy Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$2.01 |
Daily Change: | -0.04 -1.95 |
Daily Volume: | 52,634 |
Market Cap: | US$32.680M |
May 06, 2025 April 07, 2025 April 02, 2025 March 26, 2025 March 13, 2025 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load